Time of Day Matters: Opioid Peptides Trigger Different Hormone Responses Morning vs. Afternoon
Beta-endorphin and dynorphin boosted prolactin release more in the afternoon than morning, and this daily rhythm disappeared when adrenal glands were removed — linking the body's cortisol clock to opioid hormone effects.
Quick Facts
What This Study Found
Beta-endorphin (0.5 microgram injected into the brain), dynorphin (1 microgram), and U50-488H (a kappa opioid drug, 10 mg/kg) all stimulated prolactin (PRL) release more in the afternoon (4-5 PM) than in the morning (8-9 AM).
Morphine (10 mg/kg subcutaneous), met-enkephalin (200 micrograms), and D-Met-Pro-Enk (0.5 microgram) did not show this daily rhythm. Their prolactin response was the same regardless of time.
For corticosterone (a stress hormone), the pattern was different. Morphine, D-Met-Pro-Enk, met-enkephalin, and dynorphin could only increase corticosterone in the morning, when baseline levels were low. In the afternoon, when baseline corticosterone was already high, there was no room for further increase.
Removing the adrenal glands eliminated the circadian rhythm in prolactin responses, suggesting that natural cortisol cycling drives the time-of-day differences.
Key Numbers
How They Did This
Rats were tested at two time points (8-9 AM and 4-5 PM). Opioid peptides were given by intracerebroventricular injection (into the brain) or subcutaneous injection. Plasma prolactin, ACTH, and corticosterone were measured. Some rats had their adrenal glands removed to test the role of cortisol in the circadian rhythm. Tested in rats, not people.
Why This Research Matters
This study showed that the time of day you give an opioid peptide affects how the body responds. This has implications for anyone studying opioid effects on hormones. The finding that adrenal hormones control this rhythm connects the stress system to the opioid system in a time-dependent way.
The Bigger Picture
This study demonstrated that peptide hormones don't work in isolation — their effects depend on the body's circadian rhythms. This principle is now recognized across pharmacology: the timing of drug and supplement administration can significantly affect outcomes, a concept known as chronopharmacology.
What This Study Doesn't Tell Us
Tested in rats, not people. Brain injections bypass normal routes. The study used only two time points; a full 24-hour profile would be more informative. Adrenalectomy is a drastic intervention that changes many systems beyond just removing cortisol cycling.
Questions This Raises
- ?Does timing of opioid peptide exposure matter for pain management outcomes?
- ?Do these circadian patterns apply to humans as well as rats?
Trust & Context
- Key Stat:
- Afternoon > morning prolactin response Beta-endorphin and dynorphin stimulated significantly more prolactin release in the afternoon, a rhythm abolished by adrenalectomy
- Evidence Grade:
- Preliminary animal study using brain injections in rats. Demonstrates a biological principle but results may not directly translate to humans or natural peptide exposure.
- Study Age:
- Published in 1987. The chronopharmacology principles demonstrated here have been broadly confirmed and expanded in subsequent research.
- Original Title:
- Diurnal variation in prolactin, adrenocorticotropin and corticosterone release induced by opiate agonists in intact and adrenalectomized rats.
- Published In:
- Neuroendocrinology, 46(6), 475-80 (1987)
- Authors:
- Kiem, D T(2), Kanyicska, B(2), Stark, E(2), Fekete, M I
- Database ID:
- RPEP-00049
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Why did time of day affect opioid peptide responses?
The body's natural cortisol cycle (high in afternoon, low in morning for rats) modulated how opioid peptides affected hormone release. Removing the adrenal glands eliminated this rhythm, confirming cortisol as the key driver.
Does this mean peptide supplements should be taken at specific times?
This study was in rats with brain injections, so direct application to human supplementation is speculative. However, it supports the general principle that timing can affect how the body responds to bioactive compounds.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00049APA
Kiem, D T; Kanyicska, B; Stark, E; Fekete, M I. (1987). Diurnal variation in prolactin, adrenocorticotropin and corticosterone release induced by opiate agonists in intact and adrenalectomized rats.. Neuroendocrinology, 46(6), 475-80.
MLA
Kiem, D T, et al. "Diurnal variation in prolactin, adrenocorticotropin and corticosterone release induced by opiate agonists in intact and adrenalectomized rats.." Neuroendocrinology, 1987.
RethinkPeptides
RethinkPeptides Research Database. "Diurnal variation in prolactin, adrenocorticotropin and cort..." RPEP-00049. Retrieved from https://rethinkpeptides.com/research/kiem-1987-diurnal-variation-in-prolactin
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.